Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 971582, 5 pages
http://dx.doi.org/10.1155/2015/971582
Research Article

Duodenal Aspirates for Small Intestine Bacterial Overgrowth: Yield, PPIs, and Outcomes after Treatment at a Tertiary Academic Medical Center

Division of Gastroenterology, Department of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA

Received 13 October 2014; Accepted 7 January 2015

Academic Editor: Daiming Fan

Copyright © 2015 Diana L. Franco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Khoshini, S.-C. Dai, S. Lezcano, and M. Pimentel, “A systematic review of diagnostic tests for small intestinal bacterial overgrowth,” Digestive Diseases and Sciences, vol. 53, no. 6, pp. 1443–1454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Bures, J. Cyrany, D. Kohoutova et al., “Small intestinal bacterial overgrowth syndrome,” World Journal of Gastroenterology, vol. 16, no. 24, pp. 2978–2990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Ratuapli, T. G. Ellington, M.-T. O'Neill et al., “Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth,” The American Journal of Gastroenterology, vol. 107, no. 5, pp. 730–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. L. Gabbard, B. E. Lacy, G. M. Levine, and M. D. Crowell, “The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth,” Digestive Diseases and Sciences, vol. 59, no. 3, pp. 638–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Jacobs, C. Attaluri, and S. Rao, “Diagnostic utility of glucose breath test (GBT) versus duodenal culture for small intestinal bacterial overgrowth,” Neurogastroenterology & Motility, vol. 23, p. 16, 2011. View at Google Scholar
  6. W. D. Chey and B. Spiegel, “Proton pump inhibitors, irritable bowel syndrome, and small intestinal bacterial overgrowth: coincidence or Newton's third law revisited?” Clinical Gastroenterology and Hepatology, vol. 8, no. 6, pp. 480–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. P. Quera, E. M. M. Quigley, and S. A. M. Madrid, “Small intestinal bacterial overgrowth. An update,” Revista Medica de Chile, vol. 133, no. 11, pp. 1361–1370, 2005. View at Google Scholar · View at Scopus
  8. W. K. Lo and W. W. Chan, “Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 11, no. 5, pp. 483–490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. J. Hawkey, J. Bosc, J. E. Richter, G. Garcia-Tsao, and F. K. L. Chan, Textbook of Clinical Gastroenterology and Hepatology, John Wiley & Sons, Hoboken, NJ, USA, 2nd edition, 2012.
  10. A. Strocchi, J. Furne, C. Ellis, and M. D. Levitt, “Methanogens outcompete sulphate reducing bacteria for H2 in the human colon,” Gut, vol. 35, no. 8, pp. 1098–1101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Romagnuolo, D. Schiller, and R. J. Bailey, “Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation,” The American Journal of Gastroenterology, vol. 97, no. 5, pp. 1113–1126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. P. R. Gibson and J. S. Barrett, “The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders,” Nutrition, vol. 26, no. 11-12, pp. 1038–1043, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. Choung, K. C. Ruff, A. Malhotra et al., “Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture,” Alimentary Pharmacology & Therapeutics, vol. 33, no. 9, pp. 1059–1067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Lewis, S. Franco, G. Young, and S. J. D. O'Keefe, “Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole,” Alimentary Pharmacology and Therapeutics, vol. 10, no. 4, pp. 557–561, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Posserud, P.-O. Stotzer, E. S. Björnsson, H. Abrahamsson, and M. Simrén, “Small intestinal bacterial overgrowth in patients with irritable bowel syndrome,” Gut, vol. 56, no. 6, pp. 802–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Thorens, F. Froehlich, W. Schwizer et al., “Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study,” Gut, vol. 39, no. 1, pp. 54–59, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Bouhnik, S. Alain, and B. Flourié, “Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome,” American Journal of Gastroenterology, vol. 94, no. 5, pp. 1327–1331, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. B. S. Collins and H. C. Lin, “Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain,” Journal of Pediatric Gastroenterology and Nutrition, vol. 52, no. 4, pp. 382–386, 2011. View at Publisher · View at Google Scholar · View at Scopus